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ABSTRACT 
The concept of mental health has been dealt in Ayurveda with great emphasis. In our classical 
texts, the equilibrium of Satva-Raja-Tama is considered as foundation for perfect health status. 
The principles of Ayurveda still hold very true in managing childhood neuropsychiatric disorders. 
Medhya drugs has been used since antiquity for the effective management of the disorders. But in 
this era of scientific aptitude, it is the need of hour to practice evidence based medicine by the use 
of various Medhya drugs described in Ayurvedic texts for the management of neuropsychiatric 
disorders. 
Medhya herbs provide special nourishment to neuronal tissue and are thus used to enhance 
memory, cognition, and help in coping various neuropsychiatric problems. In this context, the 
present paper will focus on scientific exploration of Medhya dravyas like Brahmi (Bacopa 
monneri), Mandukparni (Centella asiatica), Shankhpushpi (Convolvulus pleuricaulis), Jatamansi 
(Nordostachys jatamansi) and Vacha (Acorus calamus) to validate the ancient views regarding 
effective management of neuropsychiatric disorder. 
KEYWORDS: Medicinal Plants, Brahmi (Bacopa monneri), Mandukparni (Centella asiatica), 
Shankhpushpi (Convolvulus pleuricaulis), Jatamansi (Nordostachys jatamansi) and Vacha, 
Childhood Neuropsychiatric Disorders. 
INTRODUCTION
 Neuropsychiatric disorders constitute the 
greatest stress on the children in most of the 
developed and developing countries. Problem of 
Neuropsychiatric  disorders are increasing 
throughout world at an alarming rate. 
Neuropsychiatric  disorders are common in the 
united state and internationally. An estimated of 22% 
of Americans aged 18 and older (about 1 in 5 adults) 
suffer from a diagnosable Neuropsychiatric  disorder 
in a given year. [1] 
 Cerebral dysfunction from any physical cause 
manifested by changes in mood behaviour, 
perception, memory, cognition, or judgments and/or 
psycho-physiology indicates Neuropsychiatric  
disorders.[2] Neuropsychiatric  disorder not only 
causes a terrible reduction in quality of life of the 
sufferer, it also places tremendous burden on both 
the carrier and welfare systems. Epidemiological 
studies of Indian children reveal that 
Neuropsychiatric  disorder is largely a hidden 
problem in the country. 
 There is a paucity of modern drugs/agents 
facilitating acquisition, retention, and retrieval of 
information and knowledge. Nootropic agents such as 
pirecetam[3], nefiracetam, aniracetam[4] and choline 
esterase like inhibitors like donepezil are being 
primarily used to improve memory, mood, behaviour. 
 However the resulting adverse effects 
associated with these agents have limited their 
use[5,6]. Beyond physically locating areas of damage 
and deficit, there is a great need to understand to 
work in prevention, treatment and rehabilitation 
efforts. 
 Ayurveda, The Indian system of medicine had 
developed therapeutic measures to rejuvenate whole 
functional dynamics of the body organs. This 
rejuvenation is known as Rasayana Chikitsa[7] 
(Rejuvenation therapy). Ayurveda claims that several 
plants, the “Medhya” plants (intellect promoting) 
herbs such as Brahmi (Bacopa monneri), 
Mandukparni (Centella asiatica), Shankhpushpi 
(Convolvulus pleuricaulis), Jatamansi (Nordostachys 
jatamansi) and Vacha (Acorus calamus) are beneficial 
in cognitive disorders. [8] Thus, it is supposed that 
these drugs can prove beneficial and provide 
effective and long term solution to Neuropsychiatric  
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disorders and thereby improve the quality of life and 
school performance in children. 
 Clinical and Experimental Evidences 
Regarding the Role of Various Ayurvedic Drugs in 
Neuropsychiatric  Disorders. 
1) Brahmi (Bacopa monneri) 
i. Nootropic activity 
In a study, Bacopa monnieri (BM) was evaluated 
alone and in combination with phenytoin for its 
effect. Phenytoin (PHT, 25mg/kg PO x 14 days) 
adversely affected cognitive function in the PA 
task. BM extract, (40 mg/kgx7 days), given along 
with phenytoin in the second week of the two 
week regimen, significantly reversed PHT – 
induced impairment. Both acquisition and 
retention of memory showed improvement 
without affecting its anticonvulsant activity. [9]  
ii. Memory enhancing effect 
1. In a study on the effects of Brahmi (Bacopa 
monnieri) on human memory. The results show 
a significant effect of the Bacopa monnieri on a 
test for the retention of new information. Follow 
up tests showed that the rate of learning was 
unaffected suggesting that Bacopa monneiri 
decreases the rate of forgetting of newly 
acquired information tasks assessing attention 
verbal and visual short term memory and the 
retrieval of preexperimental knowledge were 
unaffected. [10]  
2. Bacopa has also demonstrated a significant 
memory promoting effect in animal models of 
Alzheimer’s disease. [11]  
iii. Effect on cognitive function 
1. In a study, the chronic effects of an extract of 
bacopa on cognitive function in healthy human 
subjects were examined. Bacopa significantly 
improved speed of visual information processing 
measured by the IT task learning rate and 
memory consolidation compared to placebo, 
with maximal effects evident after 12 weeks. 
These findings suggest that Bacopa monnieri 
may improve higher order cognitive process that 
are critically dependent on the input of 
information from our environment such as 
learning and memory. [12]  
2. Extensive pharmacological studies, mostly 
conducted with standardized extract have 
shown that Bacopa improved the acquisition, 
retention and retrieval of learned tasks. [13]  
3. Bacoside A and B were found to facilitate the 
capacity for mental retention in rats and were 
active in both positive and negative 
reinforcement experiments. [14] 
4. In an open 4 week trial of bacopa in 35 patients 
with anxiety neurosis 12g/day of dried bacopa 
herb was given in the form of syrup. Significant 
improvement in anxiety (P<0.05), concentration 
(P<0.05) and immediate memory span (P<0.01) 
were seen as a result of the treatment. No major 
side effects were observed. [14]  
5. In a study to investigate the effect of bacopa in 
school children aged 6-8 years, 40 children were 
given bacopa syrup equivalent to 1g dried herb 
daily for 3 months, in a single-blind design. 
Immediate memory, perception and reaction/ 
performance times improved with bacopa 
treatment. No side effects were observed.[15] 
iv. Antidepressant activity 
 In a study, the standardized methanolic 
extract of Bacopa monnieri (bacoside A) was 
investigated for potential antidepressant activity 
in rodent models of depression. The effect was 
compared with the standard antidepressant drug 
imipramine. The Bacopa monneiri extract was 
given in the dose of 20 and 40 mg/kg, orally once 
daily for 5 days was found to have significant 
antidepressant activity in forced swim and learned 
helplessness models of depression and was 
comparable to that of imipramine. [16]  
v. Antistress effect 
The antistress effect of bacosides of Brahmi 
(Bacopa monneiri) was studied in adult male 
Sprague Dawley rats by administering oral doses 
of 20 and 40 mg/kg for 7 consecutive days. The 
data indicate that Bacopa has potential to 
modulate the activities of HSP 70, P450 and SOD 
(super oxide dismutase) thereby possibly allowing 
the brain to be prepared to act under adverse 
conditions such as stress. [17]  
vi. Improvement of mean reaction time 
In a placebo control, double- blind study to test the 
efficacy of Bacopa on children for six weeks, 50 
normal school children split into two groups were 
given either Bacopa or placebo. At the conclusion, 
they were evaluated for attention, concentration, 
and memory. Bacopa was shown to improve mean 
reaction time (Auditory and visual) significantly. 
[18]  
vii. Effect on behavior & increase in serotonin 
level 
In an experimental study, rats were individually 
trained in a simple T- maze until they reached a 
predetermined level of performance. They were 
then divided into three groups and given either 
nothing, diazepam (Valium), or Bacopa. At the end 
of 10 days, they were evaluated by repeating the 
T- maze trial. Those animals given Bacopa, showed 
remarkable learning and memory enhancement 
compared with the control and Valium groups. 
Furthermore, the neurochemical content of their 
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brain tissue showed an increase in the level of 
serotonin. Serotonin has been identified with 
improved spatial memory as well as anxiolytic 
benefits. [19] 
viii. Revitalization of intellectual functions 
In a study, Sharma and colleagues gave one half of 
a group of 40 healthy children (ages 6-8) Bacopa 
in a syrup base three times a day (a total of 
1.05g/day) over the course of four weeks, while 
giving the other half a placebo. Those children 
taking Bacopa were superior in matters of speed 
and accuracy in solving maze problems. Overall, 
these improvements “Vitalized” the children’s 
efficacy and their propensity to choose 
exploratory behavior and to opt for novel 
experiences in preference to familiar ones. [20]  
2) Mandukparni (Centella asiatica) 
i. Neuroprotective effect 
In an attempt to prepare neuroprotective 
compounds that were more efficacious than 
Asiatic acid itself, the chemical structure of Asiatic 
acid was modified and 36 derivatives were 
obtained. The neuroprotective activities of these 
derivatives were evaluated using primary cultures 
of rat cortical neurons insulted with the 
neurotoxin, glutamate, as an in vitro screening 
system. These results showed that these 
derivatives of Asiatic acid exerted significant 
neuroprotective effects on cultured cortical cells 
by their potentiation of cellular oxidative defense 
mechanism. That is, these may prove to be 
effciacions in protecting neurons from the 
oxidative damage caused by exposure to excess 
glutamate. [21] 
ii. Regeneration of nerves 
In a study, sub fractions of Centella ethanolic 
extract were tested (100 microg mL – 1) for 
neurite elongation in the presence of nerve growth 
factor (NGF). Greatest activity was found with a 
non-polar fraction (GKF4). Relatively Polar 
fractions (GKF 10 and GKF 13) also showed 
activity, albeit less than GKF4. Thus, centella 
contains more than one active component. Asiatic 
acid (AA). Male Sprague Dawley rats given 
Centella ethanolic extract in their drinking water 
(300-330 mg/kg-1daily) demonstrated more 
rapid functional recovery and increased axonal 
regeneration (larger caliber axons and greater 
number of myelinated axons) compared with 
controls, indicating that the axons grew at a faster 
rate. Taken together the findings indicate that 
components in Centella ethanolic extract may be 
useful for accelerating repair of damaged neurons. 
[22] 
 
iii. Learning and memory enhancing effect 
1. In an experimental study, fresh Centella asiatica 
plant extract was given orally to rat pups (n=5). 
Results showed a significant increase in the 
percent correct response (control: 86.44 + 2.33 
percent Vs Expt. 93.44 + 3.90 percent) in plant 
extract treated rats. Passive avoidance retention 
test revealed a significantly memory retention, 
dendritic intersection was significantly increased 
at all concentric circles, except at 100 micron. 
Dendritic branching points also significantly 
increased in the inner three zones. These results 
indicate a correlation between improved learning 
capacity and increased dendritic arborization in 
amygdaloid mucleus. [23]  
2. In an experimental study to evaluate the nootropic 
effect of Centella asiatica, animals were tested in 
radial arm maze to assess the learning and 
memory performance. Performance of juvenile 
and young adult mice was significantly improved 
in radial arm maze and hole board tests, but 
locomotor activity did not show any change 
compared to control. Treatment resulted in 
increased acetylcholine esterase activity in the 
hippocampus. Dendritc arborization of 
hippocampal CA3 neurons was also increased in 
terms of intersections and branching points both 
at month and 6 months. Results of the present 
investigation show that treatment during 
postnatal developmental stage with C.asiatica 
extract can influence the neuronal morphology 
and promote the higher brain functions of juvenile 
and young adult mice. [24]  
iv. Antidepressant activity 
In a study to evaluate the antidepressant activity 
of total titerpenes from gotu kola in forced 
swimming test. The effect of total titerpenes from 
gotu kola on the immobility time in forced 
swimming mice and ameliorated the imbalance of 
amino acid level. Thus, it may be concluded that 
the total titerpenes from gout kola had 
antidepressant activity. (Chen Y, Han T, Qin L, Rui 
Y, Zheng H). 
v. Effect on cognition and oxidative stress  
1. In the present study, the effect of an aquous 
extract of C.asiatica (100, 200 and 300 mg/kg for 
21days) was evaluated in i.c.v. STZ induced 
cognitive impairment and oxidative stress in rats. 
Male wistar rats were injected with STZ (3 mg/kg, 
i.c.v.) bilaterally on the days 1 and 3. Cognitive 
behavior was assessed using passive avoidance 
and elevated plus maze paradigms on the days 
13,14 and 21. Rats were killed on the day 21 for 
estimation of oxidative stress parameters 
(Malondialdehyde (MDA), glutathione, superoxide 
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dismutase and catalase) in the whole brain upon 
completion of the behavioral task. Rats treated 
with C.asiatica showed a dose dependant increase 
in cognitive behavior in both paradigms. A 
significant decrease in MDA and an increase in 
glutathione and catalase levels, were observed 
only in rats treated with 200 and 300 mg/kg 
C.asiatica. The present findings indicate that an 
aquous extract of C.asiatica is effective in 
preventing the cognitive deficits, as well as the 
oxidative stress, caused by i.c.v. STZ in rats. [25] 
2. Neonatal rat pups (7 days old) were given 
different doses of fresh leaf juice of Centella 
asiatica (CeA) orally for different period of time. 
These rats were then subjected to spatial learning 
(T-Maze) and passive avoidance tests along with 
the age matched normal saline control rats. The 
result showed improvement in spatial learning 
performance and enhanced memory retention in 
neonatal rats treated with higher doses. These 
results indicate that treatment with CeA fresh leaf 
juice during growth spurt period of neonatal rats 
enhances memory retention.[24] 
 
3) Shankhpushpi (Convolvulus pleuricaulis) 
i. CNS Depressant Activity 
Neuropharmacological activities of the methanol 
extract of the whole plant of Shankhapushpi, 
Convolvulus microphyllus sieb ex spreng 
(convolvulaceae), were studied in experimental 
animals. The extract was found to produce 
alternations in the general behavior pattern, 
reduction in spontaneous motor activity, 
hypothermia, and potentiation of phenobarbitone-
sleeping time, reduction in exploratory behavioral 
pattern and suppression of aggressive behavior. 
The extract also showed an inhibitory effect on 
conditioned avoidance response and antagonism 
to amphetamine toxicity. These findings explicitly 
suggest that the whole plant extract of C. 
microphyllus possesses a potential CNS depressant 
activity. [26] 
ii. Increase in Acquisition efficiency 
The ethanolic extract of the plant when 
administered to rats through gastric intubation at 
different time intervals showed enhanced 
neuropeptide synthesis of the brain. It induces an 
increase in brain protein content thus increasing 
acquisition efficiency.[27] 
iii. Effect on Behavior 
The alcoholic extract reduced the spontaneous 
motor activity of mice, the reduction being more 
marked in amphetamine treated hyperactive mice. 
The extract also exhibited potentiation of 
phenobarbitone (pentobarbitone) hypnosis in 
mice and morphine analgesia in albino rats. The 
extract caused a reduction in the fighting response 
of mice and abolished conditioned avoidance 
response without affecting the escape response. 
The electrically induced convulsive seizures in rats 
and tremorine-induced tremors in mice were 
antagonised by the extract. [28]  
iv.  Cytoprotective effect on Hippocampal cells  
Effects of Shankhapushpi on hippocampal neuron 
cells were studied in stressed adult Swiss albino 
white female mice. After treatment with alcoholic 
extract there was a significant increase in cells of 
CA1 and Dg. Sankhapushpi, in addition to 
improving memory has also been suggested to 
have cytoprotective antistress effect. [29] 
4) Jatamansi (Nordostachys jatamansi) 
i. Neuroprotective effect 
The protective effect of Nordostachys jatamansi 
(NJ) on neurobehavioral activities, thiobarbituric 
acid reactive substance (TBARS), reduced 
glutathione (GSH), thiol group, catalase and sodium 
potassium ATPase activities was studied in middle 
cerebral artery (MCA) occlusion model of acute 
cerebral ischemia in rats. MCA occlusion caused 
significant depletion in the contents of glutathione 
and thiol group and a significant elevation in the 
level of TBARS. The activities of Na (+) K (+) 
ATpase and catalase were decreased significant by 
MCA occlusion. The neurobehavioral activities 
(spontaneous motor activity and motor 
coordination) were also decreased significantly in 
MCA occlusion group. All the alternations induced 
by ischemia were significantly attenuated by 15 
days pretreatment of NJ (250 mg/kg p.o.) and 
correlated well with histopathology by decreasing 
the neuronal cell death following MCA occlusion 
and reperfusion. The study provides first evidence 
of effectiveness of NJ in local ischemia most 
probably by virtue of its antioxidant property. [30] 
ii. Improvement of Learning and Memory  
In a study undertaken to assess the potential of N 
Jatamansi as a memory enhancer, elevated plus 
maze and the passive avoidance paradigm were 
employed to evaluate learning and memory 
parameters. Three doses (50, 100, and 200 mg./kg. 
p.o.) of an ethanolic extract of N.jatamansi were 
administered for 8 successive days to both young 
and aged mice. The 200mg/kg dose of N.jatamansi 
ethanolic extract significantly improved learning 
and memory in young mice and also reversed the 
amnesia induced by diazepam (1 mg/kg, i.p.) and 
scopolamine (0.4mg/kg.i.p.). Furthermore, it also 
reversed aging induced amnesia due to natural 
aging of mice. As scopolamine induced amnesia was 
reversed, it is possible that the memory 
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improvement may be because of facilitation of 
cholinergic transmission in the brain. Hence, 
N.jatamansi might prove to be a useful memory 
restorative agent in the treatment of dementia seen 
in elderly persons. The underlying mechanism of 
action can be attributed to its antioxidant property. 
[31] 
iii. Sedative and tranquilizing action 
The sesquiterpene valeranone present in 
Nardostachys jatamansi was pharmacologically 
investigated in animal experiments of sedative, 
tranquilizing and antihypertensive properties. In 
some experiments, typical for tranquilizers, certain 
activities could be demonstrated such as the 
prolongation of barbiturate hypnosis, the 
impairment of rotarod performance, an 
anticonvulsive activity on electric shock and 
potentiation of the body-temperature lowering 
activity of reserpine. [32] 
5) Vacha (Acorus calamus)  
i. Neuroprotective effect 
In an experimental study, exposure of rats to acryl 
amide (ACR) caused hind limb paralysis in 58% of 
the animals on day 10 and decreased behavioral 
parameters, namely distance traveled, ambulatory 
time, stereotypic time and basal stereotypic 
movements compared with the control group. 
These rats also had a decrease in the reduced 
glutathione (GSH) content and glutathione-S-
transferase (GST) activity in the corpus striatum 
and an increase in striatal dopamine receptors. As 
evident by an increase in the binding of 3H-
spiperone to striatal membranes. Treatment with 
the ethanol: water (1:1) extract of the rhizomes of 
Acorus calamus (AC -002) increased the GSH 
content and GST activity in the corpus striatum 
while insignificant changes were observed in other 
parameters. Rats treated with ACR and AC-002 in 
combination had a lower incidence of paralysis 
(18%) compared with those treated with ACR alone 
on day 10 of the experiment. The rats also showed 
a partial recovery in other behavioral parameters. 
The levels of GSH content and GST activity 
increased in the corpus striatum, while the 
dopamine receptors decreased compared with the 
ACR treated rats. The results suggest that the 
neurobehavioral changes produced by ACR may be 
prevented following treatment with Acorus calamus 
rhizomes. [33] 
ii. Effect on electrical activity & regional 
monoamine levels in brain 
Effect of chronic administration of ethanolic extract 
of Acorus calamus (AC) was studied on spontaneous 
electrical activity and monoamine levels of brain. 
AC (200 mg/kg and 300 mg/kg) was administered 
orally to adult Holtzman strain rats for 14 days. In 
AC treated rats, electrographic recording revealed 
that there was increase in activity together with an 
increase in norepinephrine level in the cerebral 
cortex but a decrease in the midbrain and 
cerebellum. Serotonin level was increased in the 
cerebral cortex but decreased in the midbrain. 
Similarly, dopamine level as increased in the 
caudate nucleus and midbrain but decreased in the 
cerebellum. Thus AC seems to exert its depressive 
action by changing electrical activity and by 
differentially altering brain monoamine levels in 
different brain regions. [34] 
iii. Improvement of cognitive function 
Methanolic extracts of seven herbs Acorus calamus, 
Acorus graminens, Bupleurum falcatum, Dioscorea 
batatas, Epimedium koreanum, Poria cocos and 
Zizyphi jujuba used in traditional Korean medicine 
for improvement of memory and cognition in old 
age were tested for cholinesterase inhibitory 
properties using the Ellman colorimetric methods 
significant inhibition of the enzyme at 200 micro 
g/ml was observed for extracts from A. calamus 
and E. Koreanum. [35]  
iv. Monoamine oxidase inhibiting activity 
A monoamine oxidase inhibiting activity has been 
observed in the all of the Asian species of Acorus 
calamus (Opdyke, 1977). Indian researchers found 
that the sedative effect of asarone was dependent 
on the depression of the ergotropic division of the 
hypothalamus. [36] 
v. Sedative action  
A sedative action and potentiation of barbiturate 
effect (increased sleeping time, reduced body 
temperature) was observed in small animals (mice, 
rats, rabbits and cats) following intraperitoneal 
administration of the aquous and ethanolic extracts 
of both European and Asian varieties of Acorus 
calamus. [37] 
vi. Effect on neurotransmitters 
The Asian oil of A.calamus is reported to deplete 
levels of serotonin and norepinephine in the rat 
brain following intraperitoneal administration in a 
manner similar to that of resperine. [37] In contrast 
the European variety has not been found to have 
the same activity upon the CNS. [37]  
CONCLUSION 
 Increasing stress, depression, anxiety and 
increasing awareness of the disorder can be very well 
related to the alarming rise in the prevalence of 
Neuropsychiatric  disorders in children. After 
reviewing these clinical and experimental studies, it 
can be concluded that all these drugs have memory 
enhancing, cognitive improvement, antistress, 
antidepressive, neuroprotective and cytoprotective 
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properties in the line of management of 
neuropsychiatric disorder. Thus, it can be concluded 
that these drugs have potential of effective 
management in Neuropsychiatric  disorder. 
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